Sort by
Refine Your Search
-
Category
-
Country
-
Program
-
Employer
-
Field
-
interested in postdoctoral training with a translational focus. Our ideal candidate should have a Ph.D. in biological science and is knowledgeable about the basic mechanisms in cellular and molecular biology
-
informatics and precision medicine. These investments are exemplified by BioVU, a biobank of genetic material containing over 285k patient samples and Vanderbilt’s lead role in the President’s Precision
-
of the human microcirculation by merging vascular cell biology with computational science" that is funded by ZonMW. Job description Per June 1st, 2024, we have 3 vacancies for PhD students to work in the
-
master’s degree in a field related to biomedical sciences, with preference for experience in physiology or cardiovascular sciences; Experience with (endothelial or cardiac) cell culture, protein biochemistry
-
25 May 2024 Job Information Organisation/Company Amsterdam UMC Research Field Medical sciences Researcher Profile First Stage Researcher (R1) Country Netherlands Application Deadline 10 Jun 2024
-
with computational science In this project, we will study the molecular basis of endothelial integrity in the context of acute and chronic inflammatory responses. Recent work from our group showed that a
-
7 May 2024 Job Information Organisation/Company Amsterdam UMC Research Field Medical sciences Researcher Profile First Stage Researcher (R1) Country Netherlands Application Deadline 21 May 2024 - 21
-
within a Research Infrastructure? No Offer Description The labs of Alan Gerber (Amsterdam UMC, Location VUmc) and Fred van Leeuwen (Netherlands Cancer Institute, NKI) are teaming up to crack the code
-
18 Apr 2024 Job Information Organisation/Company The Netherlands Cancer Institute Research Field Medical sciences Physics Other Researcher Profile Recognised Researcher (R2) First Stage Researcher
-
biomarkers with CRISPR-Cas13. This technology is ultra-sensative and may revolutionize ‘point of care ‘cancer diagnostics. You will work with state-of-the-art sequencing technologies to profile blood samples